|
MINIREVIEW
Mammalian RGS Proteins: Barbarians at the Gate*
David M.
Berman and
Alfred G.
Gilman
From the Department of Pharmacology, University of Texas
Southwestern Medical Center, Dallas, Texas 75235
 |
INTRODUCTION |
Hundreds or thousands of chemical and physical
stimuli regulate the functions of eukaryotic cells by controlling the
activities of a surprisingly small number of core signaling units that
have been duplicated and adapted to achieve the necessary diversity. The most prevalent of these units, at least in animal cells, are three-protein modules consisting of signal recognition elements (receptors) and signal generators (effectors) whose activities are
linked and coordinated by heterotrimeric guanine nucleotide-binding proteins or G proteins.1
Collectively, mammalian cells contain hundreds of G protein-coupled receptors and dozens of effectors. It is difficult to count
functionally distinct G proteins because we do not understand the
significance of the heterogeneity offered by the possible combination
of 16 , 5 , and at least 12 subunits (for reviews, see Refs.
1-5).
GDP-bound G protein subunits have high affinity for a tight complex
of and subunits. This interaction of with  occludes the sites of interaction of both of these signaling molecules with
downstream effectors, and the inactive state is maintained by an
extremely slow rate of dissociation of GDP from the oligomer (k ~ 0.01/min). An agonist-bound receptor (typically
a 35-60-kDa protein with seven plasma membrane-spanning helices)
activates an appropriate G protein by poorly understood interactions
that promote dissociation of GDP. High intracellular concentrations of
GTP ensure a transient existence of the nucleotide-free G protein, and
binding of GTP causes conformational changes in that result in
dissociation of GTP- from  . Both of these complexes can then
activate or inhibit signaling pathways by engaging in interactions with
effectors such as adenylyl cyclases, phospholipases, cyclic nucleotide
phosphodiesterases, and ion channels. Termination of signaling is
dependent on the GTPase activity of . Typically slow
(kcat ~ 4/min) hydrolysis of GTP to GDP (which
remains protein bound) promotes dissociation of from effectors and
reassociation with  .
The slow intrinsic rate of GTP hydrolysis by G proteins is regulated
by interactions with so-called GTPase-activating proteins or GAPs. GAPs
were first recognized as regulators of protein synthesis factors and
low molecular weight GTPases such as Ras. It is now appreciated that
certain effectors in G protein-regulated pathways act as GAPs on
cognate G proteins (6, 7) and that there exists a large, newly
discovered family of GAPs for G proteins known as
regulators of G protein signaling
or RGS proteins. Although one critical biochemical property of this
novel RGS protein family has been defined, knowledge of the requisite
regulation of these regulators is negligible. There are hints, however,
that these proteins may be poised at centers of signaling to intercept
activated G proteins, acting, from a G protein's point of view, as
"barbarians at the gate" of cellular signaling.
 |
The RGS Protein Family |
RGS proteins were discovered functionally as negative regulators
of G protein signaling in Saccharomyces cerevisiae (Sst2p) (reviewed in Ref. 8) and Caenorhabditis elegans (EGL10) (9). This information converged quickly with demonstrations of interaction of a mammalian RGS protein with G i3 in a
two-hybrid screen (10); induction of related messages by mitogenic
stimuli in human B (11, 12) and T (13) cells; and identification of
related sequences by data base searches, application of polymerase
chain reaction technology, rescue of the Sst2p-deficient phenotype, and
homology-based screening (9, 14-18). These developments have been
reviewed previously by others (8, 19-21). To date, 19 mammalian genes
are known to encode proteins that contain the diagnostic RGS core
domain (Fig. 1). Typically, this
120-amino acid core is flanked on both sides by highly variable arms to constitute a 25-kDa protein. However, the RGS core may be split (observed only in lower organisms), and larger family members have been
identified (e.g. RGS3, RGS7).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
A, primary and secondary structure of
RGS4. Only the residues observed in the crystal structure are shown in
the alignment, which includes other selected RGS proteins (see Ref.
34). Secondary structure is depicted as either a helix for -helical
residues or a thick line for coil. The RGS box consists of four
segments, each defined by the color of its secondary structure:
red (segment 1), gold (segment 2),
green (segment 3), and blue (segment 4). The same
scheme identifies these segments in the tertiary structure of RGS4
(B). Residues highlighted in yellow are conserved
and form the hydrophobic core of the RGS box. Residues highlighted in
gray are conserved and make direct contacts with
G i1. The numbers beneath the alignment
indicate RGS4 residues that contact switch regions of
G i1 and the specific switch with which they interact. B, the RGS4-G i1
complex. RGS4 is drawn with the colored segments defined in
A. The Ras-like domain of G i1 is
drawn in dark gray, whereas the -helical domain is in
light gray. The three switch regions of
G i1 are shown in red.
GDP-Mg2+, bound in the active site of
G i1, is shown as a ball-and-stick model.
AlF4 is omitted from the figure for
clarity. Modified from Ref. 34, with permission.
|
|
 |
RGS Proteins Are G GAPs |
Given the genetic evidence that RGS proteins are negative
regulators of G protein signaling that act at the level of the
dissociated G subunit or above (but not on  or below), the
most obvious hypotheses were that RGS proteins might act as inhibitors
of GDP dissociation, blocking G protein activation, or stimulators of GTPase activity, facilitating deactivation. There is no evidence for
the former mechanism. However, of the eight mammalian RGS proteins that
have been examined biochemically, all act as GAPs (15, 17, 22-24).
In the absence of a receptor, the rate-limiting step in
steady-state hydrolysis of GTP by a G protein is release
of product (GDP dissociation). To examine the effect of an RGS protein
on actual hydrolysis of GTP, it is necessary to bypass the
rate-limiting step or accelerate it substantially. The first approach
requires preparation of substrate, GTP-G , by incubation of the G
protein with GTP in the absence of Mg2+. Catalysis is then
initiated by addition of Mg2+ in the presence or absence of
an RGS protein, and a single round of GTP hydrolysis is monitored over
a typical time course of seconds to minutes. Alternatively,
reconstitution of a heterotrimeric G protein with an appropriate
receptor in phospholipid vesicles permits addition of a receptor
agonist to speed product dissociation; the accelerating effect of a GAP
on steady-state GTP hydrolysis can then be measured.
RGS4 is readily expressed in bacteria and purified, and its GAP
activity has been studied most extensively. Whatever the actual mechanism for acceleration of GTP hydrolysis, GAPs such as RGS4 can be
conceptualized to act as enzymes, binding substrate (e.g. G -GTP) and facilitating its conversion to product (G -GDP)
(25-27). Parameters that characterize the reaction include affinity of the GAP for a pseudosubstrate complex (e.g. G -GTP S),
Km for "substrate" and
Vmax (estimated by measurement of initial rates
of GTP hydrolysis at varying concentrations of G -GTP), and the
pre-steady state rate of GTP hydrolysis (kcat)
at saturating concentrations of the GAP. This intrinsic rate of
hydrolysis may exceed the Vmax for steady-state
turnover of G -GTP by the GAP if, for example, dissociation of the
GAP from G -GDP is slow. The interactions of RGS4 with
G o and G t are catalytic; a single molecule of RGS4 can accelerate the GTPase activity of multiple molecules of G . The maximal rate enhancement is estimated to be
roughly 100-fold with G t (to 0.5/s at 4 °C).
Vmax and Km (at 22 °C) are
roughly 3/s and 2 µM, respectively; the affinity of RGS4
for GTP S-bound G t or G o is
approximately equal to the Km.
The capacities of G proteins to serve as substrates for RGS protein
GAPs are influenced by palmitoylation of G , at least in
vitro. Thus, palmitoylation of G z and
G i decreased their affinities for certain RGS proteins
by at least 90%, as well as the maximal rate of GTP hydrolysis (28).
These observations are particularly intriguing because palmitoylation
of G is reversible and, at least in some cases, is regulated in
response to activation of cognate receptors.
Berman et al. (26) compared affinities of GTP S-, GDP-,
and GDP-AlF4 -bound forms of
G o for RGS4 by testing their capacity to compete with
GTP-G o for the GAP. The
GDP-AlF4 -bound forms of G proteins
approximate transition-state complexes (29, 30), and RGS4 has markedly
higher affinity for this complex than for the substrate or product
complexes. Others have made similar observations with different RGS
proteins (15, 23, 31, 32). However, preferential affinity for the
transition-state complex is not always manifest. A protein designated
Gz GAP, now known to be a member of the RGS family (28),
has equally high affinities for both GTP S-G z and
GDP-AlF4 -G z (33).
The high affinity interaction between RGS4 and
G i1-GDP-AlF4
permitted crystallization and solution of the structure of the complex
at 2.8-Å resolution (34) (Fig. 1). Only the core domain of RGS4 was
visible in the crystal. Importantly, it has been demonstrated that this
domain contains all of the crucial elements for GAP activity (10, 17,
35, 36). The core of RGS4 contains a classic right-handed, antiparallel
four-helix bundle that interacts (via loops along its base) with
switches I, II, and III of G i1. The switches
of G proteins are those regions whose conformations are sensitive to
the identity of the bound nucleotide (GTP or GDP), and the residues of
switches I and II are intimately involved with binding and hydrolysis
of GTP. RGS4 does not contribute any residues that interact directly
with either GDP or AlF4 . However, a
conserved Asn residue in RGS4 (Asn128) may interact in the
ground state with the hydrolytic water molecule or with the side chain
of G i1 residue Gln204, a
critical residue that orients and polarizes the catalytic water in the
transition state. It is thus suggested that RGS4 acts as a GAP by
stabilizing the flexible switch regions of G proteins in
conformations resembling those found in the transition state, thus
lowering the activation energy barrier; Asn128 may further
contribute to the chemistry of hydrolysis by interactions with water or
Gln204.
 |
Comparison with RasGAP |
Comparisons of the activities and structures of low molecular
weight GTPases with those of heterotrimeric G proteins continue to be
useful. The basal rate of GTP hydrolysis catalyzed by Ras is 2 orders
of magnitude below that catalyzed by a typical G protein; the rates
of GAP-stimulated GTP hydrolysis by both proteins are similar. Much of
the difference in the basal activities and, thus, the correspondingly
greater efficiency of RasGAP is ascribable to a single Arg residue at
the active site of G protein subunits. Arg178 in
G i1 participates directly in catalysis by
stabilization of the negative charge on -phosphoryl oxygen atoms in
the transition state. Ras lacks such a residue and is essentially
inactive as a GTPase when compared with G i1.
RasGAP participates directly in GTP hydrolysis by insertion of an
"arginine finger" into the active site (37). RasGAP also binds to
the mobile switches of Ras, orienting Gln61 appropriately
(Gln61 corresponds to Gln204 in
G i1). The active sites of the
transition-state structures of Ras and G i1
(associated with their respective GAPs) are amazingly similar. In
particular, the critical Arg and Gln residues are in nearly identical
positions, even though the Arg residues point into the active site from
different directions, and one (G i1) is
contributed in cis, the other in trans (Fig.
2).

View larger version (125K):
[in this window]
[in a new window]
|
Fig. 2.
Superposition of the active sites of the
G i1-GDP-AlF4
(blue) and Ras-GDP-AlF3-GAP334
(orange/red) complexes. Reproduced from Ref. 37, with
permission.
|
|
 |
Specificity of RGS-G Interactions |
Early recognition of the large number of RGS proteins, a number
roughly comparable with that of G subunits, prompted speculation of
high specificity in their interactions; this has not been realized to
the extent anticipated. G protein subunits are usually categorized as members of one of four subfamilies, designated Gs (two
genes), Gi (eight genes), Gq (four genes), and
G12 (two genes). Most RGS proteins tested to date act as
GAPs toward members of the Gi subfamily and appear to
discriminate minimally among them; Gi proteins inhibit adenylyl cyclases, activate K+ channels, inhibit
Ca2+ channels, and activate cyclic nucleotide
phosphodiesterases. Some of these RGS proteins also act as GAPs toward
members of the Gq subfamily (phospholipase C activators)
(38). Because GAP assays with G q are difficult
technically, this interaction has been tested in only a few cases. GAPs
for G s and G 12 subfamily members have not
been detected, although inhibitory effects of RGS proteins on
Gs-mediated signaling pathways have been observed (see
below). Although we suspect that greater specificity of RGS-G protein interactions than is currently evident will be uncovered, it
seems clear that an explanation for the large number of RGS proteins
does not lie with any scenario resembling their 1:1 correspondence with
G protein subunits.
 |
RGS Proteins May Be Effector Antagonists |
As noted above, RGS4 binds to the switch regions of
G i1. Logically, these switches are also
involved in effector binding, because effectors interact preferentially
with GTP-bound subunits. This proximity or overlap of binding
surfaces raises the possibility that RGS proteins can compete for
effector binding to G . Such competition has been observed between
RGS4 and phospholipase C , which compete for binding to
GTP S-G q (38). In addition, both RGS4 and GAIP prevent
pertussis toxin-insensitive activation of phospholipase C by
GTP S. Because RGS4 does not stimulate hydrolysis of GTP S by G
proteins, a GAP mechanism cannot be operative. Transient expression of
RGS4 in COS-7 cells blocked activation of inositol phosphate synthesis
by AlF4 , also consistent with an
effector-antagonist mechanism (39). Similar observations have been made
with RGS proteins, G t, and its effector, the subunit
of a retinal cyclic GMP phosphodiesterase (27, 32).
Competition for effector binding would not be an effective mechanism
for negative regulation of G protein-mediated signaling by a protein
like RGS4, which is an active GAP. The interaction of RGS4 with G
proteins is transient and itself sufficient to interrupt signaling via
the GAP mechanism. The affinity of RGS4 for GDP-bound G proteins is
low and presumably insufficient to prevent recycling of G . However,
it is possible that other members of the RGS protein family might have
preferential affinity for GTP- or GDP-bound forms of , rather than
the transition-state complex. These proteins could then, in theory, act
as effector antagonists or sequestrants of such that it could not
interact with effectors or  . Either of these mechanisms would
have consequences substantially different from those of a GAP
mechanism. Simple stimulation of the GTPase activity of G
deactivates the protein and facilitates association with  ,
blocking downstream interactions by both and  . The other two
mechanisms would block signaling by but would leave  -mediated
signaling intact.
Chatterjee et al. (40) demonstrated that expression of a
truncated form of RGS3 (RGS3T) in baby hamster kidney cells impaired stimulation of cyclic AMP accumulation by the calcitonin gene-related peptide or pituitary adenylyl cyclase-activating peptide. These peptides are presumably activating Gs-coupled receptors,
and the question of mechanism is thus of considerable interest. We have tested RGS3T in vitro and detected GAP activity toward
G i and G o but not
G s.2 Direct
interactions between RGS3T and G s have not yet been
examined to evaluate the possibility that this RGS protein might act as an antagonist, blocking the binding of G s to adenylyl
cyclase. The first crystal structure of a G protein associated with
an effector has now been solved, that of G s with the
catalytic domain of adenylyl
cyclase.3 Superposition of
the structure of G i1 associated with RGS4 on that of G s associated with adenylyl cyclase suggests
that the interaction of an RGS protein with a G protein subunit
would not block binding of a G protein to adenylyl cyclase. Although both RGS4 and adenylyl cyclase bind to switch II of G , the
structures suggest that the two interactions could be accommodated
simultaneously. Speculatively, the GAP activity of certain RGS proteins
might be manifest only in the presence of ancillary molecules, such as
an effector.
 |
Regulation of RGS Proteins |
RGS proteins have voracious catalytic appetites. Their
overexpression in various cultured cells demonstrates that they are capable barbarians, in general obliterating the activities of pathways
in manners predictable from their specificities in vitro as
GAPs. For example, RGS4 and GAIP block Gi-mediated
inhibition of adenylyl cyclase (41), whereas RGS3T, RGS4, and to a
lesser extent RGS1 and RGS2 attenuate Gq- or
Gi-regulated activation of MAP kinase (14, 39, 40).
Similarly, RGS3, RGS4, and GAIP suppress G q-mediated
synthesis of inositol trisphosphate (39-42). To date, the
unanticipated result from such studies is attenuation of
receptor-mediated activation of adenylyl cyclase by RGS3T, discussed
above.
The existence of such activities dictates their scrupulous regulation
in cells. Although there are hints, we do not yet know how RGS proteins
are regulated in vivo or to what purpose. The most obvious
paradigm involves feedback desensitization of activated, G
protein-regulated pathways. Such desensitization is, of course, well
known in these signaling systems, and regulation is exerted at many
levels. The first RGS protein to be characterized, Sst2p in S. cerevisiae, fills this role and is itself regulated by control of
gene transcription (36, 43). It is likely that this will be at least a
part of the RGS protein story in mammalian cells, but broad adoption of
this paradigm is premature. There has been only one example of enhanced
transcription of a mammalian RGS protein gene in response to activation
of a G protein-coupled receptor (14), whereas regulation of
transcription of other RGS proteins has been noted in response to
expression of p53 (44) or polyclonal activation of T cells and B cells
(11-13). The apparently broad specificity of the interactions of many
RGS proteins with G proteins also dictates caution in interpretation
of the physiological consequences of RGS protein action. Will RGS
proteins act predominantly as feedback inhibitors of activated
pathways, transducers of cross-talk between signaling systems, or
both?
Even less well understood are potential roles of subcellular
localization and posttranslational modification in regulation of RGS
protein function. There are indications that these will be fruitful
areas for experimentation. Many RGS proteins have no obvious motifs to
specify localization at sites of action, but some do and there are
suggestions of others. Ret-RGS1 contains a hydrophobic domain near the
amino terminus suggestive of transmembrane insertion (17). GAIP and
Ret-RGS1 contain a cysteine string (17, 45), and GAIP is palmitoylated
and membrane-bound (45). An RGS protein was discovered as a partner
that interacts with the carboxyl-terminal cytoplasmic tail of
polycystin, a large integral membrane protein of unknown function
implicated in the genesis of polycystic renal
disease.4 RGS4 and other
members of the family appear to interact directly with adenylyl
cyclases.5 Perhaps RGS
proteins bind to effectors for G protein action, poised to intercept
and deactivate GTP-bound subunits after their dissociation
from  . Muallem and
Wilkie6 have demonstrated
that RGS protein boxes, which retain full potency and efficacy when
tested in vitro, are markedly less effective than their
full-length, "armed" counterparts when tested in
vivo.
Although the observations mentioned briefly in the previous paragraph
are in some ways disjointed and several of them are quite preliminary,
we believe they speak to an exciting future for research in this area.
Only simplistic models of RGS protein action can be drawn now (Fig.
3), and we believe they will be proven
entirely inadequate. The near future will almost certainly yield a
great deal of new information about regulation of RGS protein
concentration, activity, and localization. The specificities of their
interactions with G protein subunits will be defined, as will
interactions between RGS proteins and other cellular constituents. We
suspect that the various members of the family will play broad biological roles, not only in feedback regulation of G protein function
but also in coordination of the activities of G protein-regulated signaling systems with other related pathways.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Possible roles of RGS proteins in cellular
signaling. The activities and/or concentrations of RGS proteins
are presumably controlled by both G protein-coupled and other
regulatory pathways. The arrows drawn from effectors to RGS
proteins could represent transcriptional regulation, covalent
modification, localization, or other forms of regulation. RGS proteins,
acting as GAPs, can then exert negative regulatory influences on G
protein-coupled pathways, functioning either as feedback inhibitors or
mediators of cross-talk between regulatory pathways.
|
|
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 1997 Minireview Compendium, which
will be available in December, 1997. This is the second article of three in the
"Signaling by Heterotrimeric G Proteins Minireview Series." Title
adapted from Barbarians at the Gate. The Fall of RJR Nabisco
(Burrough, B., and Helyar, J. (1991) Harper & Row, New York).
To whom correspondence should be addressed. Tel.: 214-648-2370;
Fax: 214-648-8812.
1
The abbreviations used are: G protein,
heterotrimeric guanine nucleotide-binding regulatory protein; GAP,
GTPase-activating protein; RGS, regulator of G protein signaling;
GTP S, guanosine 5 -3-O-(thio)triphosphate; GAIP,
G -interacting protein, an RGS protein.
2
D. M. Berman and A. G. Gilman,
unpublished observation.
3
J. J. G. Tesmer, R. K. Sunahara,
A. G. Gilman, and S. R. Sprang, manuscript in
preparation.
4
G. Walz, personal communication.
5
R. K. Sunahara and A. G. Gilman,
unpublished observations.
6
S. Muallem and T. Wilkie, personal
communication.
 |
REFERENCES |
-
Gilman, A. G.
(1987)
Annu. Rev. Biochem.
56,
615-649[CrossRef][Medline]
[Order article via Infotrieve]
-
Bourne, H. R.,
Sanders, D. A.,
and McCormick, F.
(1990)
Nature
348,
125-132[CrossRef][Medline]
[Order article via Infotrieve]
-
Simon, M. I.,
Strathmann, M. P.,
and Gautam, N.
(1991)
Science
252,
802-808[Abstract/Free Full Text]
-
Hepler, J. R.,
and Gilman, A. G.
(1992)
Trends Biochem. Sci.
17,
383-387[CrossRef][Medline]
[Order article via Infotrieve]
-
Neer, E. J.
(1995)
Cell
80,
249-257[CrossRef][Medline]
[Order article via Infotrieve]
-
Berstein, G.,
Blank, J. L.,
Jhon, D. Y.,
Exton, J. H.,
Rhee, S. G.,
Ross, E. M.
(1992)
Cell
70,
411-418[CrossRef][Medline]
[Order article via Infotrieve]
-
Arshavsky, V. Y.,
and Bownds, M. D.
(1992)
Nature
357,
416-417[CrossRef][Medline]
[Order article via Infotrieve]
-
Dohlman, H. G.,
and Thorner, J.
(1997)
J. Biol. Chem.
272,
3871-3874[Free Full Text]
-
Koelle, M. R.,
and Horvitz, H. R.
(1996)
Cell
84,
115-125[CrossRef][Medline]
[Order article via Infotrieve]
-
De Vries, L.,
Mousli, M.,
Wurmser, A.,
and Farquhar, M. G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11916-11920[Abstract/Free Full Text]
-
Newton, J. S.,
Deed, R. W.,
Mitchell, E. L. D.,
Murphy, J. J.,
Norton, J. D.
(1993)
Biochim. Biophys. Acta
1216,
314-316[Medline]
[Order article via Infotrieve]
-
Hong, J. X.,
Wilson, G. L.,
Fox, C. H.,
Kehrl, J. H.
(1993)
J. Immunol.
150,
3895-3904[Abstract]
-
Siderovski, D. P.,
Heximer, S. P.,
and Forsdyke, D. R.
(1994)
Mol. Cell. Biol.
13,
125-147
-
Druey, K. M.,
Blumer, K. J.,
Kang, V. H.,
Kehrl, J. H.
(1996)
Nature
379,
742-746[CrossRef][Medline]
[Order article via Infotrieve]
-
Chen, C. K.,
Wieland, T.,
and Simon, M. I.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12885-12889[Abstract/Free Full Text]
-
Chen, C.,
Zheng, B.,
Han, J.,
and Lin, S.-C.
(1997)
J. Biol. Chem.
272,
8679-8685[Abstract/Free Full Text]
-
Faurobert, E.,
and Hurley, J. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2945-2950[Abstract/Free Full Text]
-
Snow, B. E.,
Antonio, L.,
Suggs, S.,
Gutstein, H. B.,
Siderovski, D. P.
(1997)
Biochem. Biophys. Res. Commun.
233,
770-777[CrossRef][Medline]
[Order article via Infotrieve]
-
Siderovski, D. P.,
Hessel, A.,
Chung, S.,
Mak, T. W.,
Tyers, M.
(1996)
Curr. Biol.
6,
211-212[CrossRef][Medline]
[Order article via Infotrieve]
-
Neer, E. J.
(1997)
Curr. Biol.
7,
R31-R33[CrossRef][Medline]
[Order article via Infotrieve]
-
Koelle, M. R.
(1997)
Curr. Opin. Cell Biol.
9,
143-147[CrossRef][Medline]
[Order article via Infotrieve]
-
Berman, D. M.,
Wilkie, T. M.,
and Gilman, A. G.
(1996)
Cell
86,
445-452[CrossRef][Medline]
[Order article via Infotrieve]
-
Watson, N.,
Linder, M. E.,
Druey, K. M.,
Kehrl, J. H.,
Blumer, K. J.
(1996)
Nature
383,
172-175[CrossRef][Medline]
[Order article via Infotrieve]
-
Hunt, T. W.,
Fields, T. A.,
Casey, P. J.,
Peralta, E. G.
(1996)
Nature
383,
175-177[CrossRef][Medline]
[Order article via Infotrieve]
-
Ross, E. M.
(1995)
Recent Prog. Horm. Res.
50,
207-219
-
Berman, D. M.,
Kozasa, T.,
and Gilman, A. G.
(1996)
J. Biol. Chem.
271,
27209-27212[Abstract/Free Full Text]
-
Nekrasova, E. R.,
Berman, D. M.,
Rustandi, R. R.,
Hamm, H. E.,
Gilman, A. G.,
Arshavsky, V. Y.
(1997)
Biochemistry
36,
7638-7643[CrossRef][Medline]
[Order article via Infotrieve]
-
Tu, Y.,
Wang, J.,
and Ross, E. M.
(1997)
Science
278,
1132-1135[Abstract/Free Full Text]
-
Coleman, D. E.,
Berghuis, A. M.,
Lee, E.,
Linder, M. E.,
Gilman, A. G.,
Sprang, S. R.
(1994)
Science
265,
1405-1412[Abstract/Free Full Text]
-
Sondek, J.,
Lambright, D. G.,
Noel, J. P.,
Hamm, H. E.,
Sigler, P. B.
(1994)
Nature
372,
276-279[CrossRef][Medline]
[Order article via Infotrieve]
-
Natochin, M.,
Granovsky, A. E.,
and Artemyev, N. O.
(1997)
J. Biol. Chem.
272,
17444-17449[Abstract/Free Full Text]
-
Wieland, T.,
Chen, C.-K.,
and Simon, M. I.
(1997)
J. Biol. Chem.
272,
8853-8856[Abstract/Free Full Text]
-
Wang, J.,
Tu, Y. P.,
Woodson, J.,
Song, X. L.,
Ross, E. M.
(1997)
J. Biol. Chem.
272,
5732-5740[Abstract/Free Full Text]
-
Tesmer, J. J. G.,
Berman, D. M.,
Gilman, A. G.,
Sprang, S. R.
(1997)
Cell
89,
251-261[CrossRef][Medline]
[Order article via Infotrieve]
-
Popov, S.,
Yu, K.,
Kozasa, T.,
and Wilkie, T. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7216-7220[Abstract/Free Full Text]
-
Dohlman, H. G.,
Apaniesk, D.,
Chen, Y.,
Song, J. P.,
Nusskern, D.
(1995)
Mol. Cell. Biol.
15,
3635-3643[Abstract]
-
Scheffzek, K.,
Ahmadian, M. R.,
Kabsch, W.,
Wiesmuller, L.,
Lautwein, A.,
Schmitz, F.,
and Wittinghofer, A.
(1997)
Science
277,
333-338[Abstract/Free Full Text]
-
Hepler, J. R.,
Berman, D. M.,
Gilman, A. G.,
Kozasa, T.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
428-432[Abstract/Free Full Text]
-
Yan, Y.,
Chi, P. P.,
and Bourne, H. R.
(1997)
J. Biol. Chem.
272,
11924-11927[Abstract/Free Full Text]
-
Chatterjee, T. K.,
Eapen, A. K.,
and Fisher, R. A.
(1997)
J. Biol. Chem.
272,
15481-15487[Abstract/Free Full Text]
-
Huang, C.,
Hepler, J. R.,
Gilman, A. G.,
Mumby, S. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6159-6163[Abstract/Free Full Text]
-
Neill, J. D.,
Duck, L. W.,
Sellers, J. C.,
Musgrove, L. C.,
Scheschonka, A.,
Druey, K. M.,
Kehrl, J. H.
(1997)
Endocrinology
137,
843-846
-
Dietzel, C.,
and Kurjan, J.
(1987)
Mol. Cell. Biol.
7,
4169-4177[Abstract/Free Full Text]
-
Buckbinder, L.,
Velasco-Miguel, S.,
Chen, Y.,
Xu, N.,
Talbott, R.,
Gelbert, L.,
Gao, J.,
Seizinger, B. R.,
Gutkind, J. S.,
Kley, N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7868-7872[Abstract/Free Full Text]
-
De Vries, L.,
Elenko, E.,
Hubler, L.,
Jones, T. L. Z.,
Farquhar, M. G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15203-15208[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. James, Y. Lu, Y. Liu, H. G. Vikis, and M. You
RGS17, an Overexpressed Gene in Human Lung and Prostate Cancer, Induces Tumor Cell Proliferation Through the Cyclic AMP-PKA-CREB Pathway
Cancer Res.,
March 1, 2009;
69(5):
2108 - 2116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bansal, J. A. DiVietro, H. S. Kuehn, S. Rao, K. H. Nocka, A. M. Gilfillan, and K. M. Druey
RGS13 Controls G Protein-Coupled Receptor-Evoked Responses of Human Mast Cells
J. Immunol.,
December 1, 2008;
181(11):
7882 - 7890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, J. Xing, L. Chen, X. Guo, Y. Du, C. Zhao, Y. Zhu, M. Lin, Z. Zhou, and J. Sha
RGS22, A Novel Testis-Specific Regulator of G-protein Signaling Involved in Human and Mouse Spermiogenesis along with GNA12/13 Subunits
Biol Reprod,
December 1, 2008;
79(6):
1021 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Gold, C. V. Hoang, B. W. Potts, G. Porras, E. Pioli, K. W. Kim, A. Nadjar, C. Qin, G. J. LaHoste, Q. Li, et al.
RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease
J. Neurosci.,
December 26, 2007;
27(52):
14338 - 14348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G Romero, M. Y. Zhou, L. L Yanes, M. W Plonczynski, T. R Washington, C. E Gomez-Sanchez, and E. P Gomez-Sanchez
Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion
J. Endocrinol.,
August 1, 2007;
194(2):
429 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Heximer and K. J. Blumer
RGS Proteins: Swiss Army Knives in Seven-Transmembrane Domain Receptor Signaling Networks
Sci. Signal.,
January 23, 2007;
2007(370):
pe2 - pe2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang and H. G. Dohlman
Regulation of G Protein and Mitogen-Activated Protein Kinase Signaling by Ubiquitination: Insights From Model Organisms
Circ. Res.,
December 8, 2006;
99(12):
1305 - 1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Tedford and G. W. Zamponi
Direct G Protein Modulation of Cav2 Calcium Channels
Pharmacol. Rev.,
December 1, 2006;
58(4):
837 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Romero, M. W. Plonczynski, E. P. Gomez-Sanchez, L. L. Yanes, and C. E. Gomez-Sanchez
RGS2 Is Regulated by Angiotensin II and Functions as a Negative Feedback of Aldosterone Production in H295R Human Adrenocortical Cells
Endocrinology,
August 1, 2006;
147(8):
3889 - 3897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind
Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-{beta}-Catenin Signaling Axis
Science,
December 2, 2005;
310(5753):
1504 - 1510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pereira and R. A. Cerione
A Switch 3 Point Mutation in the {alpha} Subunit of Transducin Yields a Unique Dominant-negative Inhibitor
J. Biol. Chem.,
October 21, 2005;
280(42):
35696 - 35703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Benians, M. Nobles, S. Hosny, and A. Tinker
Regulators of G-protein Signaling Form a Quaternary Complex with the Agonist, Receptor, and G-protein: A NOVEL EXPLANATION FOR THE ACCELERATION OF SIGNALING ACTIVATION KINETICS
J. Biol. Chem.,
April 8, 2005;
280(14):
13383 - 13394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kovoor, P. Seyffarth, J. Ebert, S. Barghshoon, C.-K. Chen, S. Schwarz, J. D. Axelrod, B. N. R. Cheyette, M. I. Simon, H. A. Lester, et al.
D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways
J. Neurosci.,
February 23, 2005;
25(8):
2157 - 2165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Traynor and R. R. Neubig
REGULATORs OF G PROTEIN SIGNALING & DRUGS OF ABUSE
Mol. Interv.,
February 1, 2005;
5(1):
30 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Albig and W. P. Schiemann
Identification and Characterization of Regulator of G Protein Signaling 4 (RGS4) as a Novel Inhibitor of Tubulogenesis: RGS4 Inhibits Mitogen-activated Protein Kinases and Vascular Endothelial Growth Factor Signaling
Mol. Biol. Cell,
February 1, 2005;
16(2):
609 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jeanneteau, O. Guillin, J. Diaz, N. Griffon, and P. Sokoloff
GIPC Recruits GAIP (RGS19) To Attenuate Dopamine D2 Receptor Signaling
Mol. Biol. Cell,
November 1, 2004;
15(11):
4926 - 4937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Wang, J. Cutler, J. King, and D. Palmer
Mutation of the Regulator of G Protein Signaling Crg1 Increases Virulence in Cryptococcus neoformans
Eukaryot. Cell,
August 1, 2004;
3(4):
1028 - 1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mao, Q. Zhao, M. Daigle, M. H. Ghahremani, P. Chidiac, and P. R. Albert
RGS17/RGSZ2, a Novel Regulator of Gi/o, Gz, and Gq Signaling
J. Biol. Chem.,
June 18, 2004;
279(25):
26314 - 26322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Roy, K. E. Lemberg, and P. Chidiac
Recruitment of RGS2 and RGS4 to the Plasma Membrane by G Proteins and Receptors Reflects Functional Interactions
Mol. Pharmacol.,
September 1, 2003;
64(3):
587 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Chatterjee, Z. Liu, and R. A. Fisher
Human RGS6 Gene Structure, Complex Alternative Splicing, and Role of N Terminus and G Protein {gamma}-Subunit-like (GGL) Domain in Subcellular Localization of RGS6 Splice Variants
J. Biol. Chem.,
August 8, 2003;
278(32):
30261 - 30271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Homme, C. P. Schmitt, R. Himmele, G. F. Hoffmann, O. Mehls, and F. Schaefer
Vitamin D and Dexamethasone Inversely Regulate Parathyroid Hormone-Induced Regulator of G Protein Signaling-2 Expression in Osteoblast-Like Cells
Endocrinology,
June 1, 2003;
144(6):
2496 - 2504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Benians, J. L. Leaney, and A. Tinker
Agonist unbinding from receptor dictates the nature of deactivation kinetics of G protein-gated K+ channels
PNAS,
May 13, 2003;
100(10):
6239 - 6244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Zhou, P. T. Toth, and R. J. Miller
Direct Interactions between the Heterotrimeric G Protein Subunit Gbeta 5 and the G Protein gamma Subunit-Like Domain-Containing Regulator of G Protein Signaling 11: Gain of Function of Cyan Fluorescent Protein-Tagged Ggamma 3
J. Pharmacol. Exp. Ther.,
May 1, 2003;
305(2):
460 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iacovelli, L. Salvatore, L. Capobianco, A. Picascia, E. Barletta, M. Storto, S. Mariggio, M. Sallese, A. Porcellini, F. Nicoletti, et al.
Role of G Protein-coupled Receptor Kinase 4 and beta -Arrestin 1 in Agonist-stimulated Metabotropic Glutamate Receptor 1 Internalization and Activation of Mitogen-activated Protein Kinases
J. Biol. Chem.,
March 28, 2003;
278(14):
12433 - 12442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, W. D. Singer, C. D. Wells, S. R. Sprang, and P. C. Sternweis
Mapping the Galpha 13 Binding Interface of the rgRGS Domain of p115RhoGEF
J. Biol. Chem.,
March 7, 2003;
278(11):
9912 - 9919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sterne-Marr, J. J. G. Tesmer, P. W. Day, R. P. Stracquatanio, J.-A. E. Cilente, K. E. O'Connor, A. N. Pronin, J. L. Benovic, and P. B. Wedegaertner
G Protein-coupled Receptor Kinase 2/Galpha q/11 Interaction. A NOVEL SURFACE ON A REGULATOR OF G PROTEIN SIGNALING HOMOLOGY DOMAIN FOR BINDING Galpha SUBUNITS
J. Biol. Chem.,
February 14, 2003;
278(8):
6050 - 6058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Weatherby, B. S. Zwilling, and W. P. Lafuse
Resistance of Macrophages to Mycobacterium avium Is Induced by {alpha}2-Adrenergic Stimulation
Infect. Immun.,
January 1, 2003;
71(1):
22 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Kohout and R. J. Lefkowitz
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization
Mol. Pharmacol.,
January 1, 2003;
63(1):
9 - 18.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, G. Ho, J. J. Zhang, B. Nieuwenhuijsen, W. Edris, P. K. Chanda, and K. H. Young
Regulator of G Protein Signaling Z1 (RGSZ1) Interacts with Galpha i Subunits and Regulates Galpha i-mediated Cell Signaling
J. Biol. Chem.,
December 6, 2002;
277(50):
48325 - 48332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Meng and P. J. Casey
Activation of Gz Attenuates Rap1-mediated Differentiation of PC12 Cells
J. Biol. Chem.,
November 1, 2002;
277(45):
43417 - 43424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Nlend, R. J. Bookman, G. E. Conner, and M. Salathe
Regulator of G-Protein Signaling Protein 2 Modulates Purinergic Calcium and Ciliary Beat Frequency Responses in Airway Epithelia
Am. J. Respir. Cell Mol. Biol.,
October 1, 2002;
27(4):
436 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hollinger and J. R. Hepler
Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling
Pharmacol. Rev.,
September 1, 2002;
54(3):
527 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Taylor
Src Tyrosine Kinase-Induced Loss of Luteinizing Hormone Responsiveness Is via a Ras-Dependent, Phosphatidylinositol-3-Kinase Independent Pathway
Biol Reprod,
September 1, 2002;
67(3):
789 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Martemyanov and V. Y. Arshavsky
Noncatalytic Domains of RGS9-1{middle dot}Gbeta 5L Play a Decisive Role in Establishing Its Substrate Specificity
J. Biol. Chem.,
August 30, 2002;
277(36):
32843 - 32848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Benzing, M. Kottgen, M. Johnson, B. Schermer, H. Zentgraf, G. Walz, and E. Kim
Interaction of 14-3-3 Protein with Regulator of G Protein Signaling 7 Is Dynamically Regulated by Tumor Necrosis Factor-alpha
J. Biol. Chem.,
August 30, 2002;
277(36):
32954 - 32962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Saitoh, Y. Murata, M. Odagiri, M. Itoh, H. Itoh, T. Misaka, and Y. Kubo
Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling
PNAS,
July 23, 2002;
99(15):
10138 - 10143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev.,
June 1, 2002;
54(2):
323 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Breitweg-Lehmann, C. Czupalla, R. Storm, O. Kudlacek, W. Schunack, M. Freissmuth, and B. Nurnberg
Activation and Inhibition of G Proteins by Lipoamines
Mol. Pharmacol.,
March 1, 2002;
61(3):
628 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nagahama, S. Usui, T. Shinohara, T. Yamaguchi, K. Tani, and M. Tagaya
Inactivation of G{alpha}z causes disassembly of the Golgi apparatus
J. Cell Sci.,
January 12, 2002;
115(23):
4483 - 4493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ehrlich, K. L. Buchanan, F. Tsien, G. Jiang, B. Sun, W. Uicker, C. M.R. Weemaes, D. Smeets, K. Sperling, B. H. Belohradsky, et al.
DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes
Hum. Mol. Genet.,
December 1, 2001;
10(25):
2917 - 2931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-E Xu, K. R. Skowronek, and J. Kurjan
The N Terminus of Saccharomyces cerevisiae Sst2p Plays an RGS-Domain-Independent, Mpt5p-Dependent Role in Recovery From Pheromone Arrest
Genetics,
December 1, 2001;
159(4):
1559 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Shepard, M. Yang, P. Xie, D. D. Browning, T. Voyno-Yasenetskaya, T. Kozasa, and R. D. Ye
Constitutive Activation of NF-kappa B and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Galpha 13 and RhoA
J. Biol. Chem.,
November 30, 2001;
276(49):
45979 - 45987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vaiskunaite, T. Kozasa, and T. A. Voyno-Yasenetskaya
Interaction between the Galpha Subunit of Heterotrimeric G12 Protein and Hsp90 Is Required for Galpha 12 Signaling
J. Biol. Chem.,
November 30, 2001;
276(49):
46088 - 46093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Azpiazu and N. Gautam
G Protein gamma Subunit Interaction with a Receptor Regulates Receptor-stimulated Nucleotide Exchange
J. Biol. Chem.,
November 2, 2001;
276(45):
41742 - 41747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Nestler
Psychogenomics: Opportunities for Understanding Addiction
J. Neurosci.,
November 1, 2001;
21(21):
8324 - 8327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Jeong and S. R Ikeda
Differential regulation of G protein-gated inwardly rectifying K+ channel kinetics by distinct domains of RGS8
J. Physiol.,
September 1, 2001;
535(2):
335 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagata, M. Oda, H. Nakata, Y. Shozaki, T. Kozasa, and K. Todokoro
A novel regulator of G-protein signaling bearing GAP activity for G{alpha}i and G{alpha}q in megakaryocytes
Blood,
May 15, 2001;
97(10):
3051 - 3060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Melliti, U. Meza, and B. A Adams
RGS2 blocks slow muscarinic inhibition of N-type Ca2+ channels reconstituted in a human cell line
J. Physiol.,
April 15, 2001;
532(2):
337 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Janetopoulos, T. Jin, and P. Devreotes
Receptor-Mediated Activation of Heterotrimeric G-Proteins in Living Cells
Science,
March 23, 2001;
291(5512):
2408 - 2411.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Harder, X. Lu, W. Wang, F. Buck, M. C. Gershengorn, and T. O. Bruhn
Regulator of G Protein Signaling 4 Suppresses Basal and Thyrotropin Releasing-Hormone (TRH)-Stimulated Signaling by Two Mouse TRH Receptors, TRH-R1 and TRH-R2
Endocrinology,
March 1, 2001;
142(3):
1188 - 1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Richards
New Signaling Pathways for Hormones and Cyclic Adenosine 3',5'-Monophosphate Action in Endocrine Cells
Mol. Endocrinol.,
February 1, 2001;
15(2):
209 - 218.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. M. Angeles, J. Williams, R. E. Purdy, L. Zhang, and W. J. Pearce
Effects of maturation and acute hypoxia on receptor-IP3 coupling in ovine common carotid arteries
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2001;
280(2):
R410 - R417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.M. Shin, X.-S. Zhao, X. Luo, A.K. Bera, and S. Muallem
Specificity of Ca2+ Signaling in Polarized Cells
Advances in Dental Research,
December 1, 2000;
14(1):
12 - 15.
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Preobrazhensky, S. Dragan, T. Kawano, M. A. Gavrilin, I. V. Gulina, L. Chakravarty, and P. E. Kolattukudy
Monocyte Chemotactic Protein-1 Receptor CCR2B Is a Glycoprotein That Has Tyrosine Sulfation in a Conserved Extracellular N-Terminal Region
J. Immunol.,
November 1, 2000;
165(9):
5295 - 5303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ujioka, D. L. Russell, H. Okamura, J. S. Richards, and L. L. Espey
Expression of Regulator of G-Protein Signaling Protein-2 Gene in the Rat Ovary at the Time of Ovulation
Biol Reprod,
November 1, 2000;
63(5):
1513 - 1517.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Oliveira-dos-Santos, G. Matsumoto, B. E. Snow, D. Bai, F. P. Houston, I. Q. Whishaw, S. Mariathasan, T. Sasaki, A. Wakeham, P. S. Ohashi, et al.
Regulation of T cell activation, anxiety, and male aggression by RGS2
PNAS,
October 4, 2000;
(2000)
220414397.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Melliti, U. Meza, and B. Adams
Muscarinic Stimulation of alpha 1E Ca Channels Is Selectively Blocked by the Effector Antagonist Function of RGS2 and Phospholipase C-beta 1
J. Neurosci.,
October 1, 2000;
20(19):
7167 - 7173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D Mark, S. Wittemann, and S. Herlitze
G protein modulation of recombinant P/Q-type calcium channels by regulators of G protein signalling proteins
J. Physiol.,
October 1, 2000;
528(1):
65 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Rebecchi and S. N. Pentyala
Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C
Physiol Rev,
October 1, 2000;
80(4):
1291 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cho, T. Kozasa, K. Takekoshi, J. De Gunzburg, and J. H. Kehrl
RGS14, a GTPase-Activating Protein for Gialpha , Attenuates Gialpha - and G13alpha -Mediated Signaling Pathways
Mol. Pharmacol.,
September 1, 2000;
58(3):
569 - 576.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. M. Sullivan, K. J. Harrison-Lavoie, V. Marshansky, H. Y. Lin, J. H. Kehrl, D. A. Ausiello, D. Brown, and K. M. Druey
RGS4 and RGS2 Bind Coatomer and Inhibit COPI Association with Golgi Membranes and Intracellular Transport
Mol. Biol. Cell,
September 1, 2000;
11(9):
3155 - 3168.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Xu, X. X. Li, F. E. Albrecht, U. Hopfer, R. M. Carey, and P. A. Jose
Dopamine1 Receptor, Gs{alpha}, and Na+-H+ Exchanger Interactions in the Kidney in Hypertension
Hypertension,
September 1, 2000;
36(3):
395 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-Q. Dong, D. Chase, G. A. Patikoglou, and M. R. Koelle
Multiple RGS proteins alter neural G protein signaling to allow C. elegans to rapidly change behavior when fed
Genes & Dev.,
August 15, 2000;
14(16):
2003 - 2014.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.-S. Myung and J. C. Garrison
Role of C-terminal domains of the G protein beta subunit in the activation of effectors
PNAS,
August 1, 2000;
97(16):
9311 - 9316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Jeong and S. R. Ikeda
Endogenous Regulator of G-Protein Signaling Proteins Modify N-Type Calcium Channel Modulation in Rat Sympathetic Neurons
J. Neurosci.,
June 15, 2000;
20(12):
4489 - 4496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sabri, E. Pak, S. A. Alcott, B. A. Wilson, and S. F. Steinberg
Coupling Function of Endogenous {alpha}1- and {beta}-Adrenergic Receptors in Mouse Cardiomyocytes
Circ. Res.,
May 26, 2000;
86(10):
1047 - 1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Reif and J. G. Cyster
RGS Molecule Expression in Murine B Lymphocytes and Ability to Down-Regulate Chemotaxis to Lymphoid Chemokines ,2
J. Immunol.,
May 1, 2000;
164(9):
4720 - 4729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Maier, A. Babich, N. Macrez, D. Leopoldt, P. Gierschik, D. Illenberger, and B. Nurnberg
Gbeta 5gamma 2 Is a Highly Selective Activator of Phospholipid-dependent Enzymes
J. Biol. Chem.,
April 28, 2000;
275(18):
13746 - 13754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Womack, S. E. Gordon, F. He, T. G. Wensel, C.-C. Lu, and D. W. Hilgemann
Do Phosphatidylinositides Modulate Vertebrate Phototransduction?
J. Neurosci.,
April 15, 2000;
20(8):
2792 - 2799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sallese, S. Mariggiò, E. D'Urbano, L. Iacovelli, and A. De Blasi
Selective Regulation of Gq Signaling by G Protein-Coupled Receptor Kinase 2: Direct Interaction of Kinase N Terminus with Activated Galpha q
Mol. Pharmacol.,
April 1, 2000;
57(4):
826 - 831.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Pedram, M. Razandi, J. Kehrl, and E. R. Levin
Natriuretic Peptides Inhibit G Protein Activation. MEDIATION THROUGH CROSS-TALK BETWEEN CYCLIC GMP-DEPENDENT PROTEIN KINASE AND REGULATORS OF G PROTEIN-SIGNALING PROTEINS
J. Biol. Chem.,
March 15, 2000;
275(10):
7365 - 7372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Grant, B. Lassègue, K. K. Griendling, M. Ushio-Fukai, P. R. Lyons, and R. W. Alexander
Specific Regulation of RGS2 Messenger RNA by Angiotensin II in Cultured Vascular Smooth Muscle Cells
Mol. Pharmacol.,
March 1, 2000;
57(3):
460 - 467.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Moratz, V. H. Kang, K. M. Druey, C.-S. Shi, A. Scheschonka, P. M. Murphy, T. Kozasa, and J. H. Kehrl
Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Gi{alpha} Signaling Responses of B Lymphocytes
J. Immunol.,
February 15, 2000;
164(4):
1829 - 1838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vorobiov, A. K. Bera, T. Keren-Raifman, R. Barzilai, and N. Dascal
Coupling of the Muscarinic m2 Receptor to G Protein-activated K+ Channels via Galpha z and a Receptor-Galpha z Fusion Protein. FUSION BETWEEN THE RECEPTOR AND Galpha z ELIMINATES CATALYTIC (COLLISION) COUPLING
J. Biol. Chem.,
February 11, 2000;
275(6):
4166 - 4170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Busconi, J. Guan, and B. M. Denker
Degradation of Heterotrimeric Galpha o Subunits via the Proteosome Pathway Is Induced by the hsp90-specific Compound Geldanamycin
J. Biol. Chem.,
January 21, 2000;
275(3):
1565 - 1569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Miles, J. P. Sluka, R. F. Santerre, L. V. Hale, L. Bloem, G. Boguslawski, K. Thirunavukkarasu, J. M. Hock, and J. E. Onyia
Dynamic Regulation of RGS2 in Bone: Potential New Insights into Parathyroid Hormone Signaling Mechanisms
Endocrinology,
January 1, 2000;
141(1):
28 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tu, S. Popov, C. Slaughter, and E. M. Ross
Palmitoylation of a Conserved Cysteine in the Regulator of G Protein Signaling (RGS) Domain Modulates the GTPase-activating Activity of RGS4 and RGS10
J. Biol. Chem.,
December 31, 1999;
274(53):
38260 - 38267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Garrison, Y. Zhang, M. Pausch, D. Apanovitch, R. Aebersold, and H. G. Dohlman
Feedback Phosphorylation of an RGS Protein by MAP Kinase in Yeast
J. Biol. Chem.,
December 17, 1999;
274(51):
36387 - 36391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Meng, J. L. Glick, P. Polakis, and P. J. Casey
Functional Interaction between Galpha z and Rap1GAP Suggests a Novel Form of Cellular Cross-talk
J. Biol. Chem.,
December 17, 1999;
274(51):
36663 - 36669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, S. Y. Neo, X. Wang, J. Han, and S.-C. Lin
Axin Forms a Complex with MEKK1 and Activates c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase through Domains Distinct from Wnt Signaling
J. Biol. Chem.,
December 3, 1999;
274(49):
35247 - 35254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Carman, J.-L. Parent, P. W. Day, A. N. Pronin, P. M. Sternweis, P. B. Wedegaertner, A. G. Gilman, J. L. Benovic, and T. Kozasa
Selective Regulation of Galpha q/11 by an RGS Domain in the G Protein-coupled Receptor Kinase, GRK2
J. Biol. Chem.,
November 26, 1999;
274(48):
34483 - 34492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Steinberg
The Molecular Basis for Distinct {beta}-Adrenergic Receptor Subtype Actions in Cardiomyocytes
Circ. Res.,
November 26, 1999;
85(11):
1101 - 1111.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Potenza, S. J. Gold, A. Roby-Shemkowitz, M. R. Lerner, and E. J. Nestler
Effects of Regulators of G Protein-Signaling Proteins on the Functional Response of the {micro}-Opioid Receptor in a Melanophore-Based Assay
J. Pharmacol. Exp. Ther.,
November 1, 1999;
291(2):
482 - 491.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. M. Hosey
What molecular events underlie heterologous desensitization? Focus on "Receptor phosphorylation does not mediate cross talk between muscarinic M3 and bradykinin B2 receptors"
Am J Physiol Cell Physiol,
November 1, 1999;
277(5):
C856 - C858.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, J. A. Frost, M. H. Cobb, and E. M. Ross
Reciprocal Signaling between Heterotrimeric G Proteins and the p21-stimulated Protein Kinase
J. Biol. Chem.,
October 29, 1999;
274(44):
31641 - 31647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Posner, A. G. Gilman, and B. A. Harris
Regulators of G Protein Signaling 6 and 7. PURIFICATION OF COMPLEXES WITH Gbeta 5 AND ASSESSMENT OF THEIR EFFECTS ON G PROTEIN-MEDIATED SIGNALING PATHWAYS
J. Biol. Chem.,
October 22, 1999;
274(43):
31087 - 31093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Song, P. De Sarno, and R. S. Jope
Muscarinic Receptor Stimulation Increases Regulators of G-protein Signaling 2 mRNA Levels through a Protein Kinase C-dependent Mechanism
J. Biol. Chem.,
October 15, 1999;
274(42):
29689 - 29693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Morris and C. C. Malbon
Physiological Regulation of G Protein-Linked Signaling
Physiol Rev,
October 1, 1999;
79(4):
1373 - 1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Jalili, Y. Takeishi, and R. A Walsh
Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC {beta}I, and PKC
Cardiovasc Res,
October 1, 1999;
44(1):
5 - 9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Denecke, A. Meyerdierks, and E. C. Bottger
RGS1 Is Expressed in Monocytes and Acts as a GTPase-activating Protein for G-protein-coupled Chemoattractant Receptors
J. Biol. Chem.,
September 17, 1999;
274(38):
26860 - 26868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Guerrero and K. P. Minneman
Coupling Efficiencies of beta 1- and beta 2-Adrenergic Receptors Expressed Alone or Together in Transfected GH3 Pituitary Cells
J. Pharmacol. Exp. Ther.,
September 1, 1999;
290(3):
980 - 988.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Mukhopadhyay and E. M. Ross
Rapid GTP binding and hydrolysis by Gq promoted by receptor and GTPase-activating proteins
PNAS,
August 17, 1999;
96(17):
9539 - 9544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Cunningham, T. M. Filtz, and T. K. Harden
Protein Kinase C-Promoted Inhibition of Galpha 11-Stimulated Phospholipase C-beta Activity
Mol. Pharmacol.,
August 1, 1999;
56(2):
265 - 271.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. M. Hajdu-Cronin, W. J. Chen, G. Patikoglou, M. R. Koelle, and P. W. Sternberg
Antagonism between Goalpha and Gqalpha in Caenorhabditis elegans: the RGS protein EAT-16 is necessary for Goalpha signaling and regulates Gqalpha activity
Genes & Dev.,
July 15, 1999;
13(14):
1780 - 1793.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Chidiac and E. M. Ross
Phospholipase C-beta 1 Directly Accelerates GTP Hydrolysis by Galpha q and Acceleration Is Inhibited by Gbeta gamma Subunits
J. Biol. Chem.,
July 9, 1999;
274(28):
19639 - 19643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chen, K. T. Seow, K. Guo, L. P. Yaw, and S.-C. Lin
The Membrane Association Domain of RGS16 Contains Unique Amphipathic Features That Are Conserved in RGS4 and RGS5
J. Biol. Chem.,
July 9, 1999;
274(28):
19799 - 19806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Polo-Parada and G. Pilar
kappa - and µ-Opioids Reverse the Somatostatin Inhibition of Ca2+ Currents in Ciliary and Dorsal Root Ganglion Neurons
J. Neurosci.,
July 1, 1999;
19(13):
5213 - 5227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Druey, O. Ugur, J. M. Caron, C.-K. Chen, P. S. Backlund, and T. L. Z. Jones
Amino-terminal Cysteine Residues of RGS16 Are Required for Palmitoylation and Modulation of Gi- and Gq-mediated Signaling
J. Biol. Chem.,
June 25, 1999;
274(26):
18836 - 18842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Luo, W. Zeng, X. Xu, S. Popov, I. Davignon, T. M. Wilkie, S. M. Mumby, and S. Muallem
Alternate Coupling of Receptors to Gs and Gi in Pancreatic and Submandibular Gland Cells
J. Biol. Chem.,
June 18, 1999;
274(25):
17684 - 17690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Woulfe and J. M. Stadel
Structural Basis for the Selectivity of the RGS Protein, GAIP, for Galpha i Family Members. IDENTIFICATION OF A SINGLE AMINO ACID DETERMINANT FOR SELECTIVE INTERACTION OF Galpha i SUBUNITS WITH GAIP
J. Biol. Chem.,
June 18, 1999;
274(25):
17718 - 17724.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|